Alan Wookey, Companion Diagnostics and Oncology Scientific Advisor at Q² Solutions along with Kristina McGuire, Sr. Director & Head of CDx and Lab operations at Regeneron and Shirin Hasan, Associate, Vice President Head of Global Clinical Affairs at Agilent and Trevor Page, Chief Business Officer, Companion Diagnostics at Agilent deliver a shared vision on building a best-in-class model for global CDx clinical trial deployment. 

The panel discussion will cover the following topics:

• The intricacies of the partnership between pharmaceutical/biotechnology drug developer, the clinical central lab and the diagnostic company that lead to a successful global Dx/CDx launch
• How the field of companion diagnostics has changed from the beginning of a program to the finish line
• The novel and creative approaches needed to enable a successful CDx program
• How to maintain the highest level of data integrity across multiple organizations on a global scale

Download the presentation slides or watch the full panel discussion including the Q&A session